Resultats de la cerca - Soamnauth Misir
- Mostrar 1 - 3 resultats de 3
-
1
Impact of lung metastasis on overall survival (OS) in the phase III SELECT study with lenvatinib (LEN) in patients (pts) with radioiodine refractory differentiated thyroid cancer (... per Makoto Tahara, Naomi Kiyota, Ana O. Hoff, Corin Badiu, Taofeek K. Owonikoko, Corina E. Dutcus, Takuya Suzuki, Min Ren, Soamnauth Misir, Lori J. Wirth
Publicat 2019Artigo -
2
Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Ca... per Angel Alsina, Masatoshi Kudo, Arndt Vogel, Ann‐Lii Cheng, Won Young Tak, Baek‐Yeol Ryoo, T.R. Jeffry Evans, Carlos López, Bruno Daniele, Soamnauth Misir, Min Ren, Namiki Izumi, Shukui Qin, Richard S. Finn
Publicat 2019Artigo -
3
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer per Lori J. Wirth, Marcia S. Brose, Eric J. Sherman, Lisa Licitra, Martin Schlumberger, Steven I. Sherman, Keith C. Bible, Bruce Robinson, Patrice Rodien, Yann Godbert, Christelle de la Fouchardière, Kate Newbold, Christopher M. Nutting, Soamnauth Misir, Ran Xie, A. Almonte, Weifei Ye, Maria E. Cabanillas
Publicat 2021Artigo
Eines de cerca:
Matèries relacionades
Gastroenterology
Internal medicine
Medicine
Oncology
Astrobiology
Confidence interval
Hazard ratio
Lenvatinib
Physics
Post-hoc analysis
Refractory (planetary science)
Adverse effect
Alternative medicine
Anaplastic thyroid cancer
Cancer
Chemotherapy
Clinical trial
Environmental health
Hepatocellular carcinoma
Interim analysis
Lung cancer
Pathology
Placebo
Population
Progression-free survival
Proportional hazards model
Sorafenib
Surgery
Thyroid cancer
Urology